Antimicrobial Resistance: A Threat to Global Healthcare and Economies

The world is facing an existential threat from antimicrobial resistance (AMR), which contributes to over 4.5 million deaths every year and has the potential to undermine the effectiveness of available antibiotics. Despite the alarming rate at which bacteria are developing resistance, the global response remains slow, with solutions under-prioritized and under-resourced. Anticipatory governance can play a crucial role in addressing this threat by enhancing AMR surveillance, coordinating healthcare operations, and fostering multisectoral collaboration.

Key Takeaways:

• AMR contributes to over 4.5 million deaths every year and has the potential to undermine the effectiveness of available antibiotics.
• The global response to AMR remains slow, with solutions under-prioritized and under-resourced.
• Anticipatory governance can enhance AMR surveillance by rethinking how we collect and use surveillance data, transforming it into early-warning systems.
• Surveillance must shift from forecasts to foresight, exploring multiple possible futures rather than predicting the most likely one.
• Foresight can leverage AI, predictive models, trend analysis, and scenario simulations to map antibiotic-resistance trajectories and identify the most effective points for intervention.
• Anticipatory governance can also coordinate siloed healthcare operations into a comprehensive, multisectoral system, fostering collaboration through inclusive, participatory mechanisms that engage a broader range of actors.
• Promising approaches, such as the NHS antimicrobial subscription model and the US Armed Forces Antimicrobial Monitoring and Research Programme, illustrate the potential of this inclusive model.
• Adaptive policy, which embeds foresight, inclusiveness, and adaptive policy into routine practice, can provide an optimal lens through which to view the AMR challenge.

Statistics:

• Over 4.5 million deaths every year are contributed to by AMR.
• The accelerating rate of resistance is projected to cost the global economy trillions.
• As much as 10% of the value of the world's publicly traded companies is exposed to AMR-related risks.
• Routine healthcare events like childbirth, cancer care, and surgery carry ever-increasing infectious risks.

Sources:

• World Economic Forum, Fast-rising antimicrobial resistance (AMR) threatens lives, global healthcare systems and the world economy.
• UN High-Level Meeting on Antimicrobial Resistance, 2024.
• EU's EpiPulse platform, tracks pathogens and resistance genes across member states.
• UK's Oxford Nanopore partnership, brings real-time genomic sequencing into NHS hospitals.
• World Health Organization, structured civilian-military collaboration for health emergencies.